Latest Boardroom Shifts News

Yugo Metals is pushing ahead with exploration in Bosnia and Herzegovina, backed by a fresh $5 million capital raise and encouraging early gold results at its Sinjakovo Project. Preparations are underway for new drilling at Cajnice, while the company continues to expand its footprint in battery and base metals.

Equus Energy has completed a critical Pre-FEED study for its Equus Gas Project, confirming two cost-effective development pathways and initiating commercial partnerships. The company also strengthened its board and maintains a solid cash position heading into FEED.

Infini Resources has launched its first-ever diamond drilling campaign at the Reynolds Lake and Reitenbach Lake uranium projects in Saskatchewan, while final assays from its Portland Creek Phase 2 drilling confirm a structurally controlled uranium system over a 6 km strike.

Arafura Rare Earths has taken a decisive step forward on its Nolans Project, announcing a Final Investment Decision and securing over A$700 million in cash and term deposits as it prepares to start construction in September 2026.

Skin Elements has secured an exclusive New Zealand distribution agreement for its ECO-Nurture bio-stimulant, raised $1.47 million through options and placement, and refreshed its board after shareholder votes.

Rokeby Resources (ASX: RKB) has secured the high-grade Omeo Gold Project, renewed a key mining licence, and launched a drilling campaign at Sunnyside to upgrade historical gold resources while raising $4.34 million.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.

Oceana Metals has validated extensive high-grade rare earth mineralisation at its Serra Negra project in Brazil, underpinning a major drilling campaign backed by a $20 million capital raise.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

Cue Energy Resources posted a solid quarter with a 16% production rise and $13.6 million cash receipts, backed by new drilling and a refreshed board after Horizon Oil's takeover.